Would screening for lung cancer benefit 75- to 84-year-old residents of the United States?

Frontiers in Oncology

Volumn 4 MAR, Issue , 2014, Pages

  Varlotto, John M ^a   DeCamp, Malcolm M ^b   Flickinger, John C ^c   Lake, Jessica ^d   Recht, Abram ^e   Belani, Chandra P ^d,f   Reed, Michael F ^d,g   Toth, Jennifer W ^d,g   Mackley, Heath B ^d,f   Sciamanna, Christopher N ^d   Lipton, Alan ^d,f   Ali, Suhail M ^d,f   Mahraj, Richkesvar P M ^d   Gilbert, Christopher R ^d,g   Yao, Nengliang ^h  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^f PENN STATE CANCER INSTITUTE   (United States)

^g PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^h VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Elderly; Lung cancer; Radiotherapy; Screening; Thoracic surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; CANCER SPECIFIC SURVIVAL; COHORT ANALYSIS; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; INCIDENCE; LIFE EXPECTANCY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MARRIAGE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RISK BENEFIT ANALYSIS; TUMOR VOLUME; UNITED STATES;

EID: 84900992973     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2014.00037     Document Type: Article

References (40)

1. National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med (2011) 365(5):395-409. doi:10.1056/NEJMoa1102873.
2. International Early Lung Cancer Action Program Investigators, Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med (2006) 355(17):1763-71. doi:10.1056/NEJMoa060476.
3. Canadian Partnership Against Cancer. System Performance Report 2010. Toronto: Canadian Partnership Against Cancer (2010).
4. Jacobson FL, Austin JHM, Field JK, Jett JR, Keshavjee S, MacMahon H, et al. Development of the American Association for Thoracic Surgery guidelines for low-dose computed tomographic scans to screen for lung cancer in North America: recommendations of the American Association for Thoracic Surgery Task Force for lung cancer screening and surveillance. J Thorac Cardiovasc Surg (2012) 144(1):25-32. doi:10.1016/j.jtcvs.2012.05.059.
5. Minimo AM, Murphy SL. Death in the United States, 2010. NCHS Data Brief (2012) 99:1-7.
6. National Center for Health Statistics. Health, United States, 2011: With Special Feature on Socioeconomic Status and Health. Hyattsville, MD: National Center for Health Statistics (2012).
7. Surveillance, Epidemiology, and End Results (SEER) Program. SEER Public-use Data (1973-2009). Bethesda, MD: National Cancer Institute, DCCPS, Surveillance Research Statistics Branch (2012). Available from: http://seer.cancer.gov/registries/list.html.
8. Surveillance, Epidemiology, and End Results (SEER) Program. SEER Public-use Data (1973-2009). Bethesda, MD: National Cancer Institute, DCCPS, Surveillance Research Statistics Branch (2012). Available from: http://www.seer.cancer.gov/.
9. Varlotto JM, Recht A, Flickinger JC, Medford-Davis LN, Dyer AM, DeCamp MM. Lobectomy leads to optimal survival in early-stage small cell lung cancer: a retrospective analysis. J Thorac Cardiovasc Surg (2011) 142(3):538-46. doi:10.1016/j.jtcvs.2010.11.062.
10. Chow GC. Tests of equality between sets of coefficients in two linear regressions. Econometrica (1960) 28:591-605. doi:10.2307/1910133.
11. Kaplan ES, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc (1958) 53:475-80. doi:10.1080/01621459.1958.10501452.
12. Cox DR. Regression models and life tables. J R Stat Soc (1972) 34:187-220.
13. Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, et al. Benefits and harms of CT screening for lung cancer: a systemic review. JAMA (2012) 308:1324-35. doi:10.1001/jama.2012.5521.
14. National Comprehensive Cancer Network. Fort Washington, PA (2012). Available from: http://www.nccn.org/patients/guidelines/lung_screening/index.html.
15. Saghir Z, Dirksen A, Ashraf H, Bach KS, Brodersen J, Clementsen PF, et al. CT screening for lung cancer brings forward early disease: the randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax (2012) 67(4):296-301. doi:10.1136/thoraxjnl-2011-200736.
16. Lopes Pegna A, Picozzi G, Mascalchi M, Maria Carozzi F, Carrozzi L, Comin C, et al. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer (2009) 64(1):34-40. doi:10.1016/j.lungcan.2008.07.003.
17. Infante M, Cavuto S, Lutman FR, Brambilla G, Chiesa G, Ceresoli G, et al. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med (2009) 180(5):445-53. doi:10.1164/rccm.200901-0076OC.
18. Gohagan JK, Marcus PM, Fagerstrom RM, Pinsky PF, Kramer BS, Prorok PC, et al. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer (2005) 47(1):9-15. doi:10.1016/j.lungcan.2004.06.007.
19. van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med (2009) 361(23):2221-9. doi:10.1056/NEJMoa0906085.
20. Blanchon T, Bréchot JM, Grenier PA, Ferretti GR, Lemarié E, Milleron B, et al. Baseline results of the Dépiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer (2007) 58(1):50-8. doi:10.1016/j.lungcan.2007.05.009.
21. Garg K, Keith RL, Byers T, Kelly K, Kerzner AL, Lynch DA, et al. Randomized controlled trial with low-dose spiral CT for lung cancer screening: feasibility study and preliminary results. Radiology (2002) 225(2):506-10. doi:10.1148/radiol.2252011851.
22. Kalucka S. Social aspects of tobacco addiction and the quality of life of people smoking and non-smoking tobacco. Przegl Lek (2012) 69(10):908-13.
23. McGarry RC, Song G, des Rosiers P. Observation-only management of early stage, medically inoperable lung cancer: poor outcome. Chest (2002) 121:1155-8. doi:10.1378/chest.121.4.1155.
24. Varlotto J, Fakiris A, Flickinger J, Medford-Davis L, Liss A, Shelkey J, et al. Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery. Cancer (2013) 119(15):2683-91. doi:10.1002/cncr.28100.
25. Mets OM, de Jong PA, Prokop M. Computed tomographic screening for lung cancer: an opportunity to evaluate other diseases. JAMA (2012) 308:1433-4. doi:10.1001/jama.2012.12656.
26. American Cancer Society. (2012). Available from: http://www.cancer.org/cancer/cancercauses/tobaccocancer/tobacco-related-cancer-fact-sheet.
27. Wells JM, Washko GR, Han MK, Abbas N, Nath H, Mamary AJ, et al. Pulmonary arterial enlargement and acute exacerbations of COPD. New Engl J Med (2012) 367:913-21. doi:10.1056/NEJMoa1203830.
28. Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med (2011) 365(13):1184-92. doi:10.1056/NEJMoa1105482.
29. Chansky K, Sculier JP, Crowley JJ. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol (2009) 4(7):792-801. doi:10.1097/JTO.0b013e3181a7716e.
30. NSCLC Meta-Analyses Collaborative Group. Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials. J Clin Oncol (2008) 26(28):4617-25. doi:10.1200/JCO.2008.17.7162.
31. Kohler BA, Ward E, McCarthy BJ, Schymura MJ, Ries LA, Eheman C, et al. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst (2011) 103:714-36. doi:10.1093/jnci/djr077.
32. Green J, Winfeld N. How accurate are hospital discharge data for evaluating effectiveness of care? Med Care (1993) 31(8):719-31. doi:10.1097/00005650-199308000-00005.
33. Glance LG, Osler TM, Mukamel DB, Dick AW. Impact of the present-on-admission indicator on hospital quality measurement: experience with the Agency for Healthcare Research and Quality (AHRQ) Inpatient Quality Indicators. Med Care (2008) 46(2):112-9. doi:10.1097/MLR.0b013e318158aed6.
34. Romano PS, Roos LL, Luft HS, Jollis JG, Doliszny K. A comparison of administrative versus clinical data: coronary artery bypass surgery as an example. Ischemic Heart Disease Patient Outcomes Research Team. J Clin Epidemiol (1994) 47:249-60. doi:10.1016/0895-4356(94)90006-X.
35. De Groot P, Munden RF. Lung cancer epidemiology, risk factors, and prevention. Radiol Clin North Am (2012) 50(5):863-76. doi:10.1016/j.rcl.2012.06.006.
36. Kovalchik SA, Tammemagi M, Berg CD, Caporaso NE, Riley TL, Korch M, et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med (2013) 369:245-54. doi:10.1056/NEJMoa1301851.
37. Hannan EL, Radzyner M, Rubin D, Dougherty J, Brennan MF. The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer. Surgery (2002) 131(1):6-15. doi:10.1067/msy.2002.120238.
38. Bach PB, Cramer LD, Schrag D, Downey RJ, Gelfand SE, Begg CB. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med (2001) 345(3):181-8. doi:10.1056/NEJM200107193450306.
39. Palma D, Visser O, Lagerwaard FJ, Belderbos J, Slotman BJ, Senan S. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis. J Clin Oncol (2010) 28(35):5153-9. doi:10.1200/JCO.2010.30.0731.
40. Shirvani SM, Jiang J, Chang JY, Welsh JW, Gomez DR, Swisher S, et al. Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys (2012) 84(5):1060-70. doi:10.1016/j.ijrobp.2012.07.2354.